FIDELIO DKD Results
Investigator Gerasimos Filippatos, MD summarizes the results of FIDELIO-DKD, which examined whether finerenone affected cardiovascular outcomes in patients with chronic kidney disease and T2DM.
See the abstract, data summary, publication link and more at https://professional.heart.org/en/meetings/scientific-sessions/science-news-2020
Видео FIDELIO DKD Results канала AHAScienceNews
See the abstract, data summary, publication link and more at https://professional.heart.org/en/meetings/scientific-sessions/science-news-2020
Видео FIDELIO DKD Results канала AHAScienceNews
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
Aldosterone Antagonists for The Management of Diabetic Kidney: FIDELIO-DKD. Prof. Hussein Sheashaa
Nephrotic Syndrome vs Nephritic Syndrome Explained (Nephritic vs Nephrotic)
Acute Kidney Injury / Acute Renal Failure Explained Clearly - BUN Creatinine Ratio
Atherosclerosis (2009)
Gastric Acid Physiology (Secretion, Ulcers, Acid Reflux and Treatment)
Reata CEO on drug that shows signs of reversing kidney damage
What is a Stroke? (HealthSketch)
Bayer | Who We Are
Nephrotic & Nephritic Syndrome | Causes , Symptoms & Treatment | Nephrology
Diabetic Kidney Disease: 2021 Update
Supplement concerns for kidney disease patients: Mayo Clinic Radio
Pneumonia Explained Clearly by MedCram.com
Endocrinology - Insulin
Cardiovascular Research Discoveries - March 2022 (Mauro Giacca and Christian Bär)
Understanding COPD
Bilirubin Metabolism
Mechanism of action of Spironolactone
FIDELIO-DKD AND FIGARO-DKD TRIAL SUMMARY - FINRENONE
Thomas Sowell on the second edition of Intellectuals and Society
Treatment of type 1 diabetes mellitus - insulin therapy